1. Home
  2. STVN vs WAY Comparison

STVN vs WAY Comparison

Compare STVN & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • WAY
  • Stock Information
  • Founded
  • STVN 1949
  • WAY 1999
  • Country
  • STVN Italy
  • WAY United States
  • Employees
  • STVN N/A
  • WAY N/A
  • Industry
  • STVN Containers/Packaging
  • WAY
  • Sector
  • STVN Consumer Discretionary
  • WAY
  • Exchange
  • STVN Nasdaq
  • WAY Nasdaq
  • Market Cap
  • STVN 7.4B
  • WAY 6.7B
  • IPO Year
  • STVN 2021
  • WAY 2024
  • Fundamental
  • Price
  • STVN $24.66
  • WAY $37.00
  • Analyst Decision
  • STVN Buy
  • WAY Strong Buy
  • Analyst Count
  • STVN 4
  • WAY 14
  • Target Price
  • STVN $25.13
  • WAY $45.29
  • AVG Volume (30 Days)
  • STVN 355.2K
  • WAY 2.5M
  • Earning Date
  • STVN 11-04-2025
  • WAY 10-29-2025
  • Dividend Yield
  • STVN 0.26%
  • WAY N/A
  • EPS Growth
  • STVN 6.78
  • WAY N/A
  • EPS
  • STVN 0.57
  • WAY 0.48
  • Revenue
  • STVN $1,344,798,591.00
  • WAY $1,011,303,000.00
  • Revenue This Year
  • STVN $8.33
  • WAY $11.28
  • Revenue Next Year
  • STVN $10.12
  • WAY $10.38
  • P/E Ratio
  • STVN $41.95
  • WAY $76.46
  • Revenue Growth
  • STVN 5.28
  • WAY 17.14
  • 52 Week Low
  • STVN $17.12
  • WAY $26.95
  • 52 Week High
  • STVN $28.00
  • WAY $48.11
  • Technical
  • Relative Strength Index (RSI)
  • STVN 48.72
  • WAY 48.25
  • Support Level
  • STVN $23.01
  • WAY $36.29
  • Resistance Level
  • STVN $24.83
  • WAY $38.00
  • Average True Range (ATR)
  • STVN 1.29
  • WAY 1.19
  • MACD
  • STVN -0.15
  • WAY -0.16
  • Stochastic Oscillator
  • STVN 40.34
  • WAY 41.31

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

Share on Social Networks: